Sydney Tatsuno Md Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 868 Ululani St Ste 102, Hilo, HI 96720 Phone: 808-969-1671 Fax: 808-969-7557 |
Kaimana Integrative Health Inc. Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 192 Kapiolani St, Hilo, HI 96720 Phone: 808-300-2432 |
Hawaii Island Community Health Center Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 305 Wailuku Dr Ste 2a, Hilo, HI 96720 Phone: 808-965-3047 |
Alan C Desilva Md Inc Internal Medicine Medicare: Medicare Enrolled Practice Location: 1248 Kinoole St Ste 107, Hilo, HI 96720 Phone: 808-935-6888 Fax: 808-961-0889 |
Lorraine Sonoda-fogel Md Inc. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1190 Waianuenue Ave, Hilo, HI 96720 Phone: 808-974-4700 |
Kaiser Permanente Hawaii Hilo Clinic Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 1292 Waianuenue Ave, Hilo, HI 96720 Phone: 808-934-4000 |
Hawaii Island Healthcare Inc Family Medicine Medicare: Medicare Enrolled Practice Location: 75 Puuhonu Pl Ste 205, Hilo, HI 96720 Phone: 808-969-3814 Fax: 808-934-7496 |
Linden Family Medicine Clinic Llc Family Medicine Medicare: Medicare Enrolled Practice Location: 400 Hualani St, Ste 196, Hilo, HI 96720 Phone: 808-961-0146 Fax: 808-969-3378 |
Pradeepta Chowdhury, Md, Llc Clinic/Center Medicare: Medicare Enrolled Practice Location: 670 Ponahawai St, Ste 116, Hilo, HI 96720 Phone: 808-961-3404 Fax: 808-961-5460 |
Hilo Family Health Clinic, Inc. Family Medicine Medicare: Medicare Enrolled Practice Location: 73 Puuhonu Pl, Suite 200, Hilo, HI 96720 Phone: 808-969-7922 Fax: 808-934-2037 |
Maika'i Health Community Clinic Clinic/Center - Community Health Medicare: Medicare Enrolled Practice Location: 670 Ponahawai St Ste 206, Hilo, HI 96720 Phone: 808-896-2732 |
Aaron H. Morita, M.d., F.a.c.p., Inc. Internal Medicine Medicare: Medicare Enrolled Practice Location: 670 Ponahawai St Ste 223, Hilo, HI 96720 Phone: 808-935-5411 Fax: 808-935-5413 |
Okahara & Olsen M.d.,inc. Family Medicine Medicare: Medicare Enrolled Practice Location: 670 Ponahawai St, Suite 208, Hilo, HI 96720 Phone: 808-935-2112 Fax: 808-935-2110 |
Sheareen Gedayloo Md Llc Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 1028 Kinoole St Ste 101, Hilo, HI 96720 Phone: 808-935-1193 Fax: 808-969-1224 |
Kevin Kurohara, M.d. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 75 Puuhonu Pl Ste 205, Hilo, HI 96720 Phone: 808-969-3814 Fax: 808-934-7496 |
Kuuahi Mobile Medical Clinic/Center Medicare: Medicare Enrolled Practice Location: 101 Aupuni St Ste 313, Hilo, HI 96720 Phone: 808-366-6106 |
News Archive
The U.S. Food and Drug Administration today finalized a new food safety rule under the landmark, bipartisan FDA Food Safety Modernization Act that will help to prevent wide-scale public health harm by requiring companies in the United States and abroad to take steps to prevent intentional adulteration of the food supply.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
Published in the Advanced Functional Materials, University of Minnesota researcher Hongbo Pang led a cross-institutional study on improving the efficacy of nucleotide-based drugs against prostate cancer and bone metastasis.
The Bill & Melinda Gates Foundation is "set to expand its involvement" with the entertainment industry and "spend more money on influencing popular culture" through a new deal with Viacom, the parent company to television networks that include MTV, VH1, Nickelodeon and BET, the New York Times reports.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled a Division of Metabolic and Endocrine Drug Products Advisory Committee meeting on December 7, 2010 to review the Company's New Drug Application (NDA) for Contrave® (naltrexone sustained release (SR)/bupropion SR) for the treatment of obesity.
› Verified 5 days ago